Advertiser / Brand
Royal Philips vs STADA
Structured technology and market comparison · 2026
Direct Feature Comparison
Royal Philips · vs · STADADutch health technology company serving providers and consumers.
Pharmaceutical group selling generics, specialty medicines and consumer healthcare.
Analyze all overlapping signals and tech stacks for Royal Philips and STADA
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between Royal Philips and STADA?
When comparing Royal Philips and STADA, both platforms operate within the Advertiser / Brand ecosystem. Royal Philips is positioned as Dutch health technology company serving providers and consumers, whereas STADA focuses on Pharmaceutical group selling generics, specialty medicines and consumer healthcare. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to Royal Philips and STADA?
When evaluating Royal Philips and STADA, enterprise buyers also consider other platforms in Advertiser / Brand. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of Royal Philips and STADA compare?
Royal Philips is headquartered in NL (founded in 1891) with >5,000 employees. STADA is based in DE (founding year unrecorded) with >5,000 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: Royal Philips vs STADA
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
Royal Philips
Recent Signals
- ·SEC APIfinancials
6-K Financial Filing Analysis for Royal Philips (2026-07-28)
Koninklijke Philips N.V. reported solid Q2 2026 financial results with group sales reaching EUR 4.36 billion, reflecting 4% comparable sales growth driven by improvements across all business segments. Income from operations increased significantly to EUR 609 million and Adjusted EBITA rose to EUR 717 million (16.4% margin), bolstered by an effective 4.2% (EUR 186 million) benefit from US tariff refunds. Net income reached EUR 386 million, up from EUR 240 million in Q2 2025. Following the recovery of US import duties, Philips upgraded its full-year 2026 Adjusted EBITA margin outlook to 13.5%-14.0% (previously 12.5%-13.0%) and increased its Free Cash Flow guidance to EUR 1.5-1.7 billion (previously EUR 1.3-1.5 billion), while reiterating comparable sales growth guidance of 3.0%-4.5%.
- Q2 2026 sales reached EUR 4,360,000,000 (+4% comparable sales growth), with net income increasing 60.8% YoY to EUR 386,000,000.
- Adjusted EBITA increased to EUR 717,000,000 (16.4% margin), including a EUR 186,000,000 US tariff refund benefit.
- Full-year 2026 outlook updated: Adjusted EBITA margin raised to 13.5%-14.0% and Free Cash Flow raised to EUR 1.5-1.7 billion; comparable sales growth reaffirmed at 3%-4.5%.
STADA
Recent Signals
- ·HorizontAgency & Consultancy
Huth+Wenzel wins Stada's Elotrans Reload account
Frankfurt-based agency Huth+Wenzel has won the creative account for Stada's Elotrans Reload. The first joint campaign is running immediately through mid-October across social media, Connected TV, linear TV (channels like RTL Zwei), digital out-of-home and ambient placements. The account move ends the prior cooperation with Schmittgall Health, which had handled the brand since the product launch in 2023. The campaign centers on a humorous fictional character named "Stefan" and the agency says it used artificial intelligence as a creative tool to develop Out-of-Home motifs. Claudia Rodrigues (Brand Manager at Stada) and Andreas Liehr (Huth+Wenzel managing director) are quoted on the campaign approach.
- Huth+Wenzel won the creative pitch for Elotrans Reload, a brand of Stada.
- The first Huth+Wenzel campaign for Elotrans Reload runs now until mid-October across social media, Connected TV, linear TV (e.g., RTL Zwei), DOOH and ambient formats.
- The account move ends Stada's prior cooperation with Schmittgall Health, which had managed Elotrans Reload since its 2023 product launch.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Royal Philips and STADA share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks